InvestorsHub Logo
Followers 839
Posts 120491
Boards Moderated 18
Alias Born 09/05/2002

Re: None

Tuesday, 03/26/2019 7:49:22 PM

Tuesday, March 26, 2019 7:49:22 PM

Post# of 430
FDA approves NVS’ Mayzent* for MS—including SPMS:

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm634469.htm

a/k/a siponimod, BAF312.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVS News